In the demanding landscape of pharmaceutical research and development, the quality and consistency of raw materials are non-negotiable. For innovators working on cutting-edge therapeutics, particularly those involving complex carbohydrate chemistry, D-Galactal (CAS 21193-75-9) stands out as a critical pharmaceutical intermediate. Its unique structural features enable the creation of sophisticated glycosylated molecules that are transforming treatments for diseases ranging from cancer to viral infections and metabolic disorders. Recognizing the importance of this compound, this guide aims to assist procurement managers and research scientists in understanding how to effectively source high-purity D-Galactal, emphasizing the advantages of partnering with reputable manufacturers and suppliers, especially those based in China.
D-Galactal's significance lies in its reactive vinyl bond, which makes it an ideal starting material for glycosylation reactions. This process is instrumental in developing drugs that exhibit improved pharmacokinetic and pharmacodynamic properties. By attaching carbohydrate moieties to drug molecules, researchers can enhance their water solubility, thereby facilitating better absorption and distribution within the body. Furthermore, glycosylation can increase a drug's stability, protecting it from degradation and prolonging its therapeutic effect. The biocompatibility of glycosylated drugs is also often superior, leading to reduced immunogenicity and improved patient tolerance. This makes D-Galactal a cornerstone for building advanced drug candidates.
The versatility of D-Galactal means it is a key ingredient in the synthesis pathways for a wide array of pharmaceutical applications. Its use is particularly prominent in the development of anticancer agents, where specific carbohydrate structures can help target cancer cells more effectively. It is also crucial in formulating antiviral drugs, where the precise modification of nucleosides or other viral inhibitors can lead to enhanced efficacy. Furthermore, research into metabolic diseases often involves the creation of complex glycan structures that mimic or modulate natural biological processes, and D-Galactal provides a fundamental building block for such endeavors. For any scientist or purchasing manager looking to buy D-Galactal for these advanced applications, purity is paramount.
When seeking to purchase D-Galactal, prioritizing high purity (typically 99% or higher) is essential to ensure successful synthesis and reproducible results. Collaborating with established manufacturers and suppliers, particularly from regions with a strong chemical manufacturing base like China, can offer significant advantages. These include access to bulk quantities, competitive pricing, and stringent quality control measures. Our company, a leading D-Galactal supplier in China, is dedicated to providing pharmaceutical R&D with precisely that – top-tier D-Galactal that meets global standards. We invite you to request a quote for D-Galactal and explore how our reliable supply chain and commitment to quality can support your critical drug development projects.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.